nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA5B—coronary artery disease	0.269	0.819	CbGaD
Topiramate—CYP2C19—coronary artery disease	0.0593	0.181	CbGaD
Topiramate—CA5A—Furosemide—coronary artery disease	0.0349	0.0958	CbGbCtD
Topiramate—CA6—Furosemide—coronary artery disease	0.0349	0.0958	CbGbCtD
Topiramate—CA7—Furosemide—coronary artery disease	0.0304	0.0835	CbGbCtD
Topiramate—CA5B—Furosemide—coronary artery disease	0.0304	0.0835	CbGbCtD
Topiramate—CA12—Furosemide—coronary artery disease	0.0261	0.0717	CbGbCtD
Topiramate—CA9—Furosemide—coronary artery disease	0.0261	0.0717	CbGbCtD
Topiramate—CA1—Furosemide—coronary artery disease	0.0244	0.0671	CbGbCtD
Topiramate—CA4—Furosemide—coronary artery disease	0.0229	0.063	CbGbCtD
Topiramate—CA2—Furosemide—coronary artery disease	0.0211	0.058	CbGbCtD
Topiramate—SCN5A—purkinje fiber—coronary artery disease	0.0126	0.247	CbGeAlD
Topiramate—CYP2C19—Gemfibrozil—coronary artery disease	0.0104	0.0285	CbGbCtD
Topiramate—CA5B—cervicothoracic ganglion—coronary artery disease	0.00987	0.193	CbGeAlD
Topiramate—CYP2C19—Clopidogrel—coronary artery disease	0.00898	0.0247	CbGbCtD
Topiramate—CYP2C19—Telmisartan—coronary artery disease	0.00785	0.0216	CbGbCtD
Topiramate—CYP3A4—Ticagrelor—coronary artery disease	0.00703	0.0193	CbGbCtD
Topiramate—SCN5A—endocardium—coronary artery disease	0.0065	0.127	CbGeAlD
Topiramate—CA5B—sinoatrial node—coronary artery disease	0.00636	0.124	CbGeAlD
Topiramate—CYP2C19—Timolol—coronary artery disease	0.00633	0.0174	CbGbCtD
Topiramate—CYP3A4—Fenofibrate—coronary artery disease	0.00627	0.0172	CbGbCtD
Topiramate—SCN5A—sinoatrial node—coronary artery disease	0.00616	0.121	CbGeAlD
Topiramate—CYP2C19—Rosuvastatin—coronary artery disease	0.00579	0.0159	CbGbCtD
Topiramate—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00564	0.0155	CbGbCtD
Topiramate—CYP2C19—Simvastatin—coronary artery disease	0.00538	0.0148	CbGbCtD
Topiramate—CYP2C19—Lovastatin—coronary artery disease	0.00527	0.0145	CbGbCtD
Topiramate—CYP3A4—Gemfibrozil—coronary artery disease	0.00501	0.0138	CbGbCtD
Topiramate—CYP2C19—Atorvastatin—coronary artery disease	0.0048	0.0132	CbGbCtD
Topiramate—CYP2C19—Losartan—coronary artery disease	0.00439	0.0121	CbGbCtD
Topiramate—CYP3A4—Clopidogrel—coronary artery disease	0.00434	0.0119	CbGbCtD
Topiramate—CYP3A4—Eplerenone—coronary artery disease	0.00404	0.0111	CbGbCtD
Topiramate—CYP3A4—Enalapril—coronary artery disease	0.0036	0.00989	CbGbCtD
Topiramate—CYP3A4—Rosuvastatin—coronary artery disease	0.0028	0.00769	CbGbCtD
Topiramate—CYP3A4—Ezetimibe—coronary artery disease	0.0028	0.00769	CbGbCtD
Topiramate—CYP3A4—Simvastatin—coronary artery disease	0.0026	0.00715	CbGbCtD
Topiramate—CYP3A4—Lovastatin—coronary artery disease	0.00255	0.007	CbGbCtD
Topiramate—CYP3A4—Pravastatin—coronary artery disease	0.00255	0.007	CbGbCtD
Topiramate—CYP3A4—Atorvastatin—coronary artery disease	0.00232	0.00638	CbGbCtD
Topiramate—CYP3A4—Losartan—coronary artery disease	0.00212	0.00583	CbGbCtD
Topiramate—GRIK5—heart—coronary artery disease	0.00131	0.0256	CbGeAlD
Topiramate—SCN5A—cardiac ventricle—coronary artery disease	0.000547	0.0107	CbGeAlD
Topiramate—SCN5A—myocardium—coronary artery disease	0.000514	0.0101	CbGeAlD
Topiramate—GRIK2—heart—coronary artery disease	0.000442	0.00865	CbGeAlD
Topiramate—CA4—cardiac ventricle—coronary artery disease	0.00039	0.00763	CbGeAlD
Topiramate—CA5B—heart—coronary artery disease	0.000371	0.00725	CbGeAlD
Topiramate—CA4—myocardium—coronary artery disease	0.000366	0.00717	CbGeAlD
Topiramate—SCN5A—heart—coronary artery disease	0.000359	0.00703	CbGeAlD
Topiramate—CA5B—cardiovascular system—coronary artery disease	0.00035	0.00684	CbGeAlD
Topiramate—SCN5A—cardiovascular system—coronary artery disease	0.000339	0.00663	CbGeAlD
Topiramate—CA1—heart—coronary artery disease	0.000327	0.00641	CbGeAlD
Topiramate—CA2—cardiac ventricle—coronary artery disease	0.000323	0.00632	CbGeAlD
Topiramate—CA5B—cardiac atrium—coronary artery disease	0.000317	0.0062	CbGeAlD
Topiramate—CA1—cardiovascular system—coronary artery disease	0.000309	0.00604	CbGeAlD
Topiramate—SCN5A—cardiac atrium—coronary artery disease	0.000307	0.00601	CbGeAlD
Topiramate—CA2—myocardium—coronary artery disease	0.000304	0.00595	CbGeAlD
Topiramate—CA5B—blood—coronary artery disease	0.000277	0.00541	CbGeAlD
Topiramate—SCN5A—blood—coronary artery disease	0.000268	0.00524	CbGeAlD
Topiramate—CA4—heart—coronary artery disease	0.000256	0.00501	CbGeAlD
Topiramate—CA1—blood—coronary artery disease	0.000244	0.00478	CbGeAlD
Topiramate—CA4—cardiovascular system—coronary artery disease	0.000241	0.00472	CbGeAlD
Topiramate—CA4—cardiac atrium—coronary artery disease	0.000219	0.00428	CbGeAlD
Topiramate—CA2—heart—coronary artery disease	0.000212	0.00415	CbGeAlD
Topiramate—CA2—cardiovascular system—coronary artery disease	0.0002	0.00392	CbGeAlD
Topiramate—CA4—blood—coronary artery disease	0.000191	0.00374	CbGeAlD
Topiramate—CA2—cardiac atrium—coronary artery disease	0.000181	0.00355	CbGeAlD
Topiramate—CYP2C19—blood—coronary artery disease	0.000173	0.00338	CbGeAlD
Topiramate—CA2—blood—coronary artery disease	0.000158	0.0031	CbGeAlD
Topiramate—CYP3A4—blood—coronary artery disease	0.000102	0.002	CbGeAlD
Topiramate—Asthenia—Niacin—coronary artery disease	2.38e-05	0.000143	CcSEcCtD
Topiramate—Fatigue—Losartan—coronary artery disease	2.38e-05	0.000143	CcSEcCtD
Topiramate—Headache—Ezetimibe—coronary artery disease	2.37e-05	0.000143	CcSEcCtD
Topiramate—Malaise—Lisinopril—coronary artery disease	2.37e-05	0.000143	CcSEcCtD
Topiramate—Oedema—Ramipril—coronary artery disease	2.37e-05	0.000142	CcSEcCtD
Topiramate—Vertigo—Lisinopril—coronary artery disease	2.36e-05	0.000142	CcSEcCtD
Topiramate—Dry mouth—Timolol—coronary artery disease	2.36e-05	0.000142	CcSEcCtD
Topiramate—Constipation—Losartan—coronary artery disease	2.36e-05	0.000142	CcSEcCtD
Topiramate—Pain—Losartan—coronary artery disease	2.36e-05	0.000142	CcSEcCtD
Topiramate—Syncope—Lisinopril—coronary artery disease	2.36e-05	0.000142	CcSEcCtD
Topiramate—Vomiting—Eplerenone—coronary artery disease	2.36e-05	0.000142	CcSEcCtD
Topiramate—Feeling abnormal—Furosemide—coronary artery disease	2.36e-05	0.000142	CcSEcCtD
Topiramate—Leukopenia—Lisinopril—coronary artery disease	2.35e-05	0.000142	CcSEcCtD
Topiramate—Nausea—Fenofibrate—coronary artery disease	2.35e-05	0.000141	CcSEcCtD
Topiramate—Pruritus—Niacin—coronary artery disease	2.35e-05	0.000141	CcSEcCtD
Topiramate—Asthenia—Pravastatin—coronary artery disease	2.34e-05	0.000141	CcSEcCtD
Topiramate—Gastrointestinal pain—Furosemide—coronary artery disease	2.34e-05	0.000141	CcSEcCtD
Topiramate—Rash—Eplerenone—coronary artery disease	2.34e-05	0.000141	CcSEcCtD
Topiramate—Urticaria—Perindopril—coronary artery disease	2.34e-05	0.000141	CcSEcCtD
Topiramate—Hypersensitivity—Trandolapril—coronary artery disease	2.34e-05	0.000141	CcSEcCtD
Topiramate—Dermatitis—Eplerenone—coronary artery disease	2.34e-05	0.000141	CcSEcCtD
Topiramate—Diarrhoea—Valsartan—coronary artery disease	2.33e-05	0.000141	CcSEcCtD
Topiramate—Confusional state—Timolol—coronary artery disease	2.33e-05	0.00014	CcSEcCtD
Topiramate—Shock—Ramipril—coronary artery disease	2.33e-05	0.00014	CcSEcCtD
Topiramate—Hypersensitivity—Enalapril—coronary artery disease	2.33e-05	0.00014	CcSEcCtD
Topiramate—Abdominal pain—Perindopril—coronary artery disease	2.33e-05	0.00014	CcSEcCtD
Topiramate—Body temperature increased—Perindopril—coronary artery disease	2.33e-05	0.00014	CcSEcCtD
Topiramate—Palpitations—Lisinopril—coronary artery disease	2.32e-05	0.00014	CcSEcCtD
Topiramate—Diarrhoea—Olmesartan—coronary artery disease	2.32e-05	0.00014	CcSEcCtD
Topiramate—Headache—Eplerenone—coronary artery disease	2.32e-05	0.00014	CcSEcCtD
Topiramate—Nervous system disorder—Ramipril—coronary artery disease	2.32e-05	0.00014	CcSEcCtD
Topiramate—Thrombocytopenia—Ramipril—coronary artery disease	2.32e-05	0.00014	CcSEcCtD
Topiramate—Oedema—Timolol—coronary artery disease	2.31e-05	0.000139	CcSEcCtD
Topiramate—Pruritus—Pravastatin—coronary artery disease	2.31e-05	0.000139	CcSEcCtD
Topiramate—Loss of consciousness—Lisinopril—coronary artery disease	2.31e-05	0.000139	CcSEcCtD
Topiramate—Nausea—Clopidogrel—coronary artery disease	2.31e-05	0.000139	CcSEcCtD
Topiramate—Tachycardia—Ramipril—coronary artery disease	2.31e-05	0.000139	CcSEcCtD
Topiramate—Skin disorder—Ramipril—coronary artery disease	2.3e-05	0.000138	CcSEcCtD
Topiramate—Infection—Timolol—coronary artery disease	2.3e-05	0.000138	CcSEcCtD
Topiramate—Vomiting—Simvastatin—coronary artery disease	2.3e-05	0.000138	CcSEcCtD
Topiramate—Hypersensitivity—Telmisartan—coronary artery disease	2.3e-05	0.000138	CcSEcCtD
Topiramate—Cough—Lisinopril—coronary artery disease	2.29e-05	0.000138	CcSEcCtD
Topiramate—Nausea—Lovastatin—coronary artery disease	2.29e-05	0.000138	CcSEcCtD
Topiramate—Hyperhidrosis—Ramipril—coronary artery disease	2.29e-05	0.000138	CcSEcCtD
Topiramate—Rash—Simvastatin—coronary artery disease	2.28e-05	0.000137	CcSEcCtD
Topiramate—Dermatitis—Simvastatin—coronary artery disease	2.28e-05	0.000137	CcSEcCtD
Topiramate—Asthenia—Trandolapril—coronary artery disease	2.28e-05	0.000137	CcSEcCtD
Topiramate—Shock—Timolol—coronary artery disease	2.28e-05	0.000137	CcSEcCtD
Topiramate—Feeling abnormal—Losartan—coronary artery disease	2.27e-05	0.000137	CcSEcCtD
Topiramate—Urticaria—Furosemide—coronary artery disease	2.27e-05	0.000137	CcSEcCtD
Topiramate—Diarrhoea—Niacin—coronary artery disease	2.27e-05	0.000137	CcSEcCtD
Topiramate—Nervous system disorder—Timolol—coronary artery disease	2.27e-05	0.000137	CcSEcCtD
Topiramate—Asthenia—Enalapril—coronary artery disease	2.27e-05	0.000136	CcSEcCtD
Topiramate—Headache—Simvastatin—coronary artery disease	2.26e-05	0.000136	CcSEcCtD
Topiramate—Body temperature increased—Furosemide—coronary artery disease	2.26e-05	0.000136	CcSEcCtD
Topiramate—Abdominal pain—Furosemide—coronary artery disease	2.26e-05	0.000136	CcSEcCtD
Topiramate—Gastrointestinal pain—Losartan—coronary artery disease	2.26e-05	0.000136	CcSEcCtD
Topiramate—Dizziness—Valsartan—coronary artery disease	2.26e-05	0.000136	CcSEcCtD
Topiramate—Anorexia—Ramipril—coronary artery disease	2.26e-05	0.000136	CcSEcCtD
Topiramate—Nausea—Ezetimibe—coronary artery disease	2.25e-05	0.000136	CcSEcCtD
Topiramate—Skin disorder—Timolol—coronary artery disease	2.25e-05	0.000135	CcSEcCtD
Topiramate—Dizziness—Olmesartan—coronary artery disease	2.25e-05	0.000135	CcSEcCtD
Topiramate—Pruritus—Trandolapril—coronary artery disease	2.24e-05	0.000135	CcSEcCtD
Topiramate—Myalgia—Lisinopril—coronary artery disease	2.24e-05	0.000135	CcSEcCtD
Topiramate—Arthralgia—Lisinopril—coronary artery disease	2.24e-05	0.000135	CcSEcCtD
Topiramate—Chest pain—Lisinopril—coronary artery disease	2.24e-05	0.000135	CcSEcCtD
Topiramate—Hyperhidrosis—Timolol—coronary artery disease	2.24e-05	0.000135	CcSEcCtD
Topiramate—Asthenia—Telmisartan—coronary artery disease	2.24e-05	0.000135	CcSEcCtD
Topiramate—Pruritus—Enalapril—coronary artery disease	2.24e-05	0.000135	CcSEcCtD
Topiramate—Diarrhoea—Pravastatin—coronary artery disease	2.23e-05	0.000135	CcSEcCtD
Topiramate—Anxiety—Lisinopril—coronary artery disease	2.23e-05	0.000134	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.22e-05	0.000134	CcSEcCtD
Topiramate—Discomfort—Lisinopril—coronary artery disease	2.21e-05	0.000133	CcSEcCtD
Topiramate—Hypotension—Ramipril—coronary artery disease	2.21e-05	0.000133	CcSEcCtD
Topiramate—Anorexia—Timolol—coronary artery disease	2.2e-05	0.000133	CcSEcCtD
Topiramate—Pruritus—Telmisartan—coronary artery disease	2.2e-05	0.000133	CcSEcCtD
Topiramate—Nausea—Eplerenone—coronary artery disease	2.2e-05	0.000133	CcSEcCtD
Topiramate—Dizziness—Niacin—coronary artery disease	2.19e-05	0.000132	CcSEcCtD
Topiramate—Urticaria—Losartan—coronary artery disease	2.19e-05	0.000132	CcSEcCtD
Topiramate—Dry mouth—Lisinopril—coronary artery disease	2.19e-05	0.000132	CcSEcCtD
Topiramate—Body temperature increased—Losartan—coronary artery disease	2.18e-05	0.000131	CcSEcCtD
Topiramate—Abdominal pain—Losartan—coronary artery disease	2.18e-05	0.000131	CcSEcCtD
Topiramate—Asthenia—Captopril—coronary artery disease	2.17e-05	0.000131	CcSEcCtD
Topiramate—Diarrhoea—Trandolapril—coronary artery disease	2.17e-05	0.000131	CcSEcCtD
Topiramate—Vomiting—Valsartan—coronary artery disease	2.17e-05	0.000131	CcSEcCtD
Topiramate—Confusional state—Lisinopril—coronary artery disease	2.16e-05	0.00013	CcSEcCtD
Topiramate—Diarrhoea—Enalapril—coronary artery disease	2.16e-05	0.00013	CcSEcCtD
Topiramate—Hypotension—Timolol—coronary artery disease	2.16e-05	0.00013	CcSEcCtD
Topiramate—Dizziness—Pravastatin—coronary artery disease	2.16e-05	0.00013	CcSEcCtD
Topiramate—Vomiting—Olmesartan—coronary artery disease	2.16e-05	0.00013	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.16e-05	0.00013	CcSEcCtD
Topiramate—Rash—Valsartan—coronary artery disease	2.15e-05	0.00013	CcSEcCtD
Topiramate—Dermatitis—Valsartan—coronary artery disease	2.15e-05	0.000129	CcSEcCtD
Topiramate—Nausea—Simvastatin—coronary artery disease	2.15e-05	0.000129	CcSEcCtD
Topiramate—Oedema—Lisinopril—coronary artery disease	2.15e-05	0.000129	CcSEcCtD
Topiramate—Pruritus—Captopril—coronary artery disease	2.14e-05	0.000129	CcSEcCtD
Topiramate—Rash—Olmesartan—coronary artery disease	2.14e-05	0.000129	CcSEcCtD
Topiramate—Insomnia—Ramipril—coronary artery disease	2.14e-05	0.000129	CcSEcCtD
Topiramate—Dermatitis—Olmesartan—coronary artery disease	2.14e-05	0.000129	CcSEcCtD
Topiramate—Headache—Valsartan—coronary artery disease	2.14e-05	0.000129	CcSEcCtD
Topiramate—Diarrhoea—Telmisartan—coronary artery disease	2.13e-05	0.000128	CcSEcCtD
Topiramate—Infection—Lisinopril—coronary artery disease	2.13e-05	0.000128	CcSEcCtD
Topiramate—Headache—Olmesartan—coronary artery disease	2.13e-05	0.000128	CcSEcCtD
Topiramate—Paraesthesia—Ramipril—coronary artery disease	2.12e-05	0.000128	CcSEcCtD
Topiramate—Shock—Lisinopril—coronary artery disease	2.11e-05	0.000127	CcSEcCtD
Topiramate—Asthenia—Perindopril—coronary artery disease	2.11e-05	0.000127	CcSEcCtD
Topiramate—Dyspnoea—Ramipril—coronary artery disease	2.11e-05	0.000127	CcSEcCtD
Topiramate—Vomiting—Niacin—coronary artery disease	2.11e-05	0.000127	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Timolol—coronary artery disease	2.11e-05	0.000127	CcSEcCtD
Topiramate—Hypersensitivity—Furosemide—coronary artery disease	2.11e-05	0.000127	CcSEcCtD
Topiramate—Somnolence—Ramipril—coronary artery disease	2.1e-05	0.000127	CcSEcCtD
Topiramate—Thrombocytopenia—Lisinopril—coronary artery disease	2.1e-05	0.000127	CcSEcCtD
Topiramate—Dizziness—Trandolapril—coronary artery disease	2.1e-05	0.000126	CcSEcCtD
Topiramate—Tachycardia—Lisinopril—coronary artery disease	2.09e-05	0.000126	CcSEcCtD
Topiramate—Insomnia—Timolol—coronary artery disease	2.09e-05	0.000126	CcSEcCtD
Topiramate—Rash—Niacin—coronary artery disease	2.09e-05	0.000126	CcSEcCtD
Topiramate—Dermatitis—Niacin—coronary artery disease	2.09e-05	0.000126	CcSEcCtD
Topiramate—Dizziness—Enalapril—coronary artery disease	2.09e-05	0.000126	CcSEcCtD
Topiramate—Skin disorder—Lisinopril—coronary artery disease	2.08e-05	0.000126	CcSEcCtD
Topiramate—Dyspepsia—Ramipril—coronary artery disease	2.08e-05	0.000125	CcSEcCtD
Topiramate—Pruritus—Perindopril—coronary artery disease	2.08e-05	0.000125	CcSEcCtD
Topiramate—Headache—Niacin—coronary artery disease	2.08e-05	0.000125	CcSEcCtD
Topiramate—Paraesthesia—Timolol—coronary artery disease	2.08e-05	0.000125	CcSEcCtD
Topiramate—Vomiting—Pravastatin—coronary artery disease	2.08e-05	0.000125	CcSEcCtD
Topiramate—Hyperhidrosis—Lisinopril—coronary artery disease	2.07e-05	0.000125	CcSEcCtD
Topiramate—Diarrhoea—Captopril—coronary artery disease	2.07e-05	0.000125	CcSEcCtD
Topiramate—Dyspnoea—Timolol—coronary artery disease	2.06e-05	0.000124	CcSEcCtD
Topiramate—Dizziness—Telmisartan—coronary artery disease	2.06e-05	0.000124	CcSEcCtD
Topiramate—Rash—Pravastatin—coronary artery disease	2.06e-05	0.000124	CcSEcCtD
Topiramate—Dermatitis—Pravastatin—coronary artery disease	2.06e-05	0.000124	CcSEcCtD
Topiramate—Decreased appetite—Ramipril—coronary artery disease	2.06e-05	0.000124	CcSEcCtD
Topiramate—Somnolence—Timolol—coronary artery disease	2.06e-05	0.000124	CcSEcCtD
Topiramate—Asthenia—Furosemide—coronary artery disease	2.05e-05	0.000124	CcSEcCtD
Topiramate—Headache—Pravastatin—coronary artery disease	2.05e-05	0.000123	CcSEcCtD
Topiramate—Anorexia—Lisinopril—coronary artery disease	2.05e-05	0.000123	CcSEcCtD
Topiramate—Gastrointestinal disorder—Ramipril—coronary artery disease	2.04e-05	0.000123	CcSEcCtD
Topiramate—Fatigue—Ramipril—coronary artery disease	2.04e-05	0.000123	CcSEcCtD
Topiramate—Dyspepsia—Timolol—coronary artery disease	2.04e-05	0.000123	CcSEcCtD
Topiramate—Hypersensitivity—Losartan—coronary artery disease	2.03e-05	0.000122	CcSEcCtD
Topiramate—Nausea—Valsartan—coronary artery disease	2.03e-05	0.000122	CcSEcCtD
Topiramate—Pruritus—Furosemide—coronary artery disease	2.02e-05	0.000122	CcSEcCtD
Topiramate—Constipation—Ramipril—coronary artery disease	2.02e-05	0.000122	CcSEcCtD
Topiramate—Nausea—Olmesartan—coronary artery disease	2.02e-05	0.000121	CcSEcCtD
Topiramate—Vomiting—Trandolapril—coronary artery disease	2.02e-05	0.000121	CcSEcCtD
Topiramate—Diarrhoea—Perindopril—coronary artery disease	2.01e-05	0.000121	CcSEcCtD
Topiramate—Decreased appetite—Timolol—coronary artery disease	2.01e-05	0.000121	CcSEcCtD
Topiramate—Vomiting—Enalapril—coronary artery disease	2.01e-05	0.000121	CcSEcCtD
Topiramate—Hypotension—Lisinopril—coronary artery disease	2.01e-05	0.000121	CcSEcCtD
Topiramate—Dizziness—Captopril—coronary artery disease	2e-05	0.000121	CcSEcCtD
Topiramate—Rash—Trandolapril—coronary artery disease	2e-05	0.00012	CcSEcCtD
Topiramate—Dermatitis—Trandolapril—coronary artery disease	2e-05	0.00012	CcSEcCtD
Topiramate—Gastrointestinal disorder—Timolol—coronary artery disease	2e-05	0.00012	CcSEcCtD
Topiramate—Fatigue—Timolol—coronary artery disease	1.99e-05	0.00012	CcSEcCtD
Topiramate—Rash—Enalapril—coronary artery disease	1.99e-05	0.00012	CcSEcCtD
Topiramate—Dermatitis—Enalapril—coronary artery disease	1.99e-05	0.00012	CcSEcCtD
Topiramate—Headache—Trandolapril—coronary artery disease	1.99e-05	0.00012	CcSEcCtD
Topiramate—Vomiting—Telmisartan—coronary artery disease	1.98e-05	0.000119	CcSEcCtD
Topiramate—Asthenia—Losartan—coronary artery disease	1.98e-05	0.000119	CcSEcCtD
Topiramate—Headache—Enalapril—coronary artery disease	1.98e-05	0.000119	CcSEcCtD
Topiramate—Pain—Timolol—coronary artery disease	1.98e-05	0.000119	CcSEcCtD
Topiramate—Nausea—Niacin—coronary artery disease	1.97e-05	0.000119	CcSEcCtD
Topiramate—Rash—Telmisartan—coronary artery disease	1.96e-05	0.000118	CcSEcCtD
Topiramate—Dermatitis—Telmisartan—coronary artery disease	1.96e-05	0.000118	CcSEcCtD
Topiramate—Diarrhoea—Furosemide—coronary artery disease	1.96e-05	0.000118	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.96e-05	0.000118	CcSEcCtD
Topiramate—Pruritus—Losartan—coronary artery disease	1.95e-05	0.000118	CcSEcCtD
Topiramate—Headache—Telmisartan—coronary artery disease	1.95e-05	0.000118	CcSEcCtD
Topiramate—Feeling abnormal—Ramipril—coronary artery disease	1.95e-05	0.000117	CcSEcCtD
Topiramate—Dizziness—Perindopril—coronary artery disease	1.95e-05	0.000117	CcSEcCtD
Topiramate—Insomnia—Lisinopril—coronary artery disease	1.94e-05	0.000117	CcSEcCtD
Topiramate—Nausea—Pravastatin—coronary artery disease	1.94e-05	0.000117	CcSEcCtD
Topiramate—Gastrointestinal pain—Ramipril—coronary artery disease	1.93e-05	0.000117	CcSEcCtD
Topiramate—Paraesthesia—Lisinopril—coronary artery disease	1.93e-05	0.000116	CcSEcCtD
Topiramate—Vomiting—Captopril—coronary artery disease	1.93e-05	0.000116	CcSEcCtD
Topiramate—Dyspnoea—Lisinopril—coronary artery disease	1.91e-05	0.000115	CcSEcCtD
Topiramate—Rash—Captopril—coronary artery disease	1.91e-05	0.000115	CcSEcCtD
Topiramate—Dermatitis—Captopril—coronary artery disease	1.91e-05	0.000115	CcSEcCtD
Topiramate—Somnolence—Lisinopril—coronary artery disease	1.91e-05	0.000115	CcSEcCtD
Topiramate—Feeling abnormal—Timolol—coronary artery disease	1.91e-05	0.000115	CcSEcCtD
Topiramate—Headache—Captopril—coronary artery disease	1.9e-05	0.000114	CcSEcCtD
Topiramate—Gastrointestinal pain—Timolol—coronary artery disease	1.89e-05	0.000114	CcSEcCtD
Topiramate—Dizziness—Furosemide—coronary artery disease	1.89e-05	0.000114	CcSEcCtD
Topiramate—Dyspepsia—Lisinopril—coronary artery disease	1.89e-05	0.000114	CcSEcCtD
Topiramate—Diarrhoea—Losartan—coronary artery disease	1.89e-05	0.000114	CcSEcCtD
Topiramate—Nausea—Trandolapril—coronary artery disease	1.88e-05	0.000113	CcSEcCtD
Topiramate—Urticaria—Ramipril—coronary artery disease	1.88e-05	0.000113	CcSEcCtD
Topiramate—Nausea—Enalapril—coronary artery disease	1.88e-05	0.000113	CcSEcCtD
Topiramate—Vomiting—Perindopril—coronary artery disease	1.87e-05	0.000113	CcSEcCtD
Topiramate—Body temperature increased—Ramipril—coronary artery disease	1.87e-05	0.000113	CcSEcCtD
Topiramate—Abdominal pain—Ramipril—coronary artery disease	1.87e-05	0.000113	CcSEcCtD
Topiramate—Decreased appetite—Lisinopril—coronary artery disease	1.87e-05	0.000112	CcSEcCtD
Topiramate—Rash—Perindopril—coronary artery disease	1.85e-05	0.000112	CcSEcCtD
Topiramate—Dermatitis—Perindopril—coronary artery disease	1.85e-05	0.000112	CcSEcCtD
Topiramate—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.85e-05	0.000112	CcSEcCtD
Topiramate—Nausea—Telmisartan—coronary artery disease	1.85e-05	0.000111	CcSEcCtD
Topiramate—Fatigue—Lisinopril—coronary artery disease	1.85e-05	0.000111	CcSEcCtD
Topiramate—Headache—Perindopril—coronary artery disease	1.84e-05	0.000111	CcSEcCtD
Topiramate—Urticaria—Timolol—coronary artery disease	1.84e-05	0.000111	CcSEcCtD
Topiramate—Pain—Lisinopril—coronary artery disease	1.84e-05	0.000111	CcSEcCtD
Topiramate—Constipation—Lisinopril—coronary artery disease	1.84e-05	0.000111	CcSEcCtD
Topiramate—Abdominal pain—Timolol—coronary artery disease	1.83e-05	0.00011	CcSEcCtD
Topiramate—Body temperature increased—Timolol—coronary artery disease	1.83e-05	0.00011	CcSEcCtD
Topiramate—Dizziness—Losartan—coronary artery disease	1.82e-05	0.00011	CcSEcCtD
Topiramate—Vomiting—Furosemide—coronary artery disease	1.82e-05	0.00011	CcSEcCtD
Topiramate—Rash—Furosemide—coronary artery disease	1.8e-05	0.000109	CcSEcCtD
Topiramate—Dermatitis—Furosemide—coronary artery disease	1.8e-05	0.000108	CcSEcCtD
Topiramate—Nausea—Captopril—coronary artery disease	1.8e-05	0.000108	CcSEcCtD
Topiramate—Headache—Furosemide—coronary artery disease	1.79e-05	0.000108	CcSEcCtD
Topiramate—Feeling abnormal—Lisinopril—coronary artery disease	1.77e-05	0.000106	CcSEcCtD
Topiramate—Gastrointestinal pain—Lisinopril—coronary artery disease	1.75e-05	0.000106	CcSEcCtD
Topiramate—Vomiting—Losartan—coronary artery disease	1.75e-05	0.000106	CcSEcCtD
Topiramate—Nausea—Perindopril—coronary artery disease	1.75e-05	0.000105	CcSEcCtD
Topiramate—Hypersensitivity—Ramipril—coronary artery disease	1.74e-05	0.000105	CcSEcCtD
Topiramate—Rash—Losartan—coronary artery disease	1.74e-05	0.000105	CcSEcCtD
Topiramate—Dermatitis—Losartan—coronary artery disease	1.74e-05	0.000105	CcSEcCtD
Topiramate—Headache—Losartan—coronary artery disease	1.73e-05	0.000104	CcSEcCtD
Topiramate—Urticaria—Lisinopril—coronary artery disease	1.7e-05	0.000103	CcSEcCtD
Topiramate—Hypersensitivity—Timolol—coronary artery disease	1.7e-05	0.000103	CcSEcCtD
Topiramate—Nausea—Furosemide—coronary artery disease	1.7e-05	0.000102	CcSEcCtD
Topiramate—Asthenia—Ramipril—coronary artery disease	1.7e-05	0.000102	CcSEcCtD
Topiramate—Abdominal pain—Lisinopril—coronary artery disease	1.7e-05	0.000102	CcSEcCtD
Topiramate—Body temperature increased—Lisinopril—coronary artery disease	1.7e-05	0.000102	CcSEcCtD
Topiramate—Pruritus—Ramipril—coronary artery disease	1.67e-05	0.000101	CcSEcCtD
Topiramate—Asthenia—Timolol—coronary artery disease	1.66e-05	9.99e-05	CcSEcCtD
Topiramate—Nausea—Losartan—coronary artery disease	1.64e-05	9.87e-05	CcSEcCtD
Topiramate—Pruritus—Timolol—coronary artery disease	1.64e-05	9.86e-05	CcSEcCtD
Topiramate—Diarrhoea—Ramipril—coronary artery disease	1.62e-05	9.75e-05	CcSEcCtD
Topiramate—Diarrhoea—Timolol—coronary artery disease	1.58e-05	9.53e-05	CcSEcCtD
Topiramate—Hypersensitivity—Lisinopril—coronary artery disease	1.58e-05	9.52e-05	CcSEcCtD
Topiramate—Dizziness—Ramipril—coronary artery disease	1.56e-05	9.42e-05	CcSEcCtD
Topiramate—Asthenia—Lisinopril—coronary artery disease	1.54e-05	9.27e-05	CcSEcCtD
Topiramate—Dizziness—Timolol—coronary artery disease	1.53e-05	9.21e-05	CcSEcCtD
Topiramate—Pruritus—Lisinopril—coronary artery disease	1.52e-05	9.14e-05	CcSEcCtD
Topiramate—Vomiting—Ramipril—coronary artery disease	1.5e-05	9.06e-05	CcSEcCtD
Topiramate—Rash—Ramipril—coronary artery disease	1.49e-05	8.98e-05	CcSEcCtD
Topiramate—Dermatitis—Ramipril—coronary artery disease	1.49e-05	8.98e-05	CcSEcCtD
Topiramate—Headache—Ramipril—coronary artery disease	1.48e-05	8.93e-05	CcSEcCtD
Topiramate—Vomiting—Timolol—coronary artery disease	1.47e-05	8.86e-05	CcSEcCtD
Topiramate—Diarrhoea—Lisinopril—coronary artery disease	1.47e-05	8.84e-05	CcSEcCtD
Topiramate—Rash—Timolol—coronary artery disease	1.46e-05	8.78e-05	CcSEcCtD
Topiramate—Dermatitis—Timolol—coronary artery disease	1.46e-05	8.77e-05	CcSEcCtD
Topiramate—Headache—Timolol—coronary artery disease	1.45e-05	8.73e-05	CcSEcCtD
Topiramate—Dizziness—Lisinopril—coronary artery disease	1.42e-05	8.55e-05	CcSEcCtD
Topiramate—Nausea—Ramipril—coronary artery disease	1.41e-05	8.46e-05	CcSEcCtD
Topiramate—Nausea—Timolol—coronary artery disease	1.37e-05	8.27e-05	CcSEcCtD
Topiramate—Vomiting—Lisinopril—coronary artery disease	1.36e-05	8.22e-05	CcSEcCtD
Topiramate—Rash—Lisinopril—coronary artery disease	1.35e-05	8.15e-05	CcSEcCtD
Topiramate—Dermatitis—Lisinopril—coronary artery disease	1.35e-05	8.14e-05	CcSEcCtD
Topiramate—Headache—Lisinopril—coronary artery disease	1.34e-05	8.1e-05	CcSEcCtD
Topiramate—Nausea—Lisinopril—coronary artery disease	1.27e-05	7.68e-05	CcSEcCtD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	4.16e-06	4.59e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—coronary artery disease	4.15e-06	4.57e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—coronary artery disease	4.13e-06	4.56e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	4.12e-06	4.55e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CKB—coronary artery disease	4.11e-06	4.54e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PYGB—coronary artery disease	4.11e-06	4.54e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—coronary artery disease	4.09e-06	4.51e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—POMC—coronary artery disease	4.09e-06	4.51e-05	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MAPK1—coronary artery disease	4.04e-06	4.46e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—coronary artery disease	4.01e-06	4.42e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—coronary artery disease	3.97e-06	4.39e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—coronary artery disease	3.96e-06	4.37e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AGT—coronary artery disease	3.93e-06	4.33e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—POMC—coronary artery disease	3.92e-06	4.33e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—coronary artery disease	3.92e-06	4.32e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK1—coronary artery disease	3.88e-06	4.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PFKFB3—coronary artery disease	3.87e-06	4.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COX5B—coronary artery disease	3.87e-06	4.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLIN1—coronary artery disease	3.87e-06	4.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM2—coronary artery disease	3.87e-06	4.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DLAT—coronary artery disease	3.87e-06	4.27e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—coronary artery disease	3.85e-06	4.24e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—coronary artery disease	3.81e-06	4.2e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOA1—coronary artery disease	3.8e-06	4.19e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—POMC—coronary artery disease	3.76e-06	4.15e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—coronary artery disease	3.73e-06	4.11e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—coronary artery disease	3.7e-06	4.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	3.68e-06	4.06e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SULT1E1—coronary artery disease	3.67e-06	4.04e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—coronary artery disease	3.57e-06	3.94e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—NOS3—coronary artery disease	3.57e-06	3.93e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	3.56e-06	3.93e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPAP2B—coronary artery disease	3.51e-06	3.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	3.51e-06	3.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CKM—coronary artery disease	3.51e-06	3.87e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.5e-06	3.87e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKR1B1—coronary artery disease	3.5e-06	3.86e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HK2—coronary artery disease	3.5e-06	3.86e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—coronary artery disease	3.43e-06	3.78e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—NOS3—coronary artery disease	3.42e-06	3.77e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC27A1—coronary artery disease	3.35e-06	3.7e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—coronary artery disease	3.35e-06	3.7e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—POMC—coronary artery disease	3.3e-06	3.65e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CPT1B—coronary artery disease	3.29e-06	3.63e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LCAT—coronary artery disease	3.29e-06	3.63e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—NOS3—coronary artery disease	3.28e-06	3.62e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PDK4—coronary artery disease	3.26e-06	3.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SULT4A1—coronary artery disease	3.26e-06	3.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CKMT2—coronary artery disease	3.26e-06	3.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	3.26e-06	3.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PYGM—coronary artery disease	3.26e-06	3.6e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—coronary artery disease	3.26e-06	3.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—POMC—coronary artery disease	3.25e-06	3.59e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA4—coronary artery disease	3.23e-06	3.56e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	3.17e-06	3.5e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—coronary artery disease	3.13e-06	3.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PDHA1—coronary artery disease	3.12e-06	3.44e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCLM—coronary artery disease	3.12e-06	3.44e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	3.02e-06	3.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP11B2—coronary artery disease	3.02e-06	3.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TXNRD1—coronary artery disease	3.02e-06	3.33e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—coronary artery disease	3.01e-06	3.32e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—coronary artery disease	3e-06	3.31e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—coronary artery disease	2.98e-06	3.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC22A3—coronary artery disease	2.97e-06	3.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ARNTL—coronary artery disease	2.93e-06	3.23e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HADH—coronary artery disease	2.93e-06	3.23e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—coronary artery disease	2.91e-06	3.21e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—coronary artery disease	2.91e-06	3.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.91e-06	3.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PFKM—coronary artery disease	2.91e-06	3.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GK—coronary artery disease	2.91e-06	3.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LDHA—coronary artery disease	2.91e-06	3.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GYG1—coronary artery disease	2.91e-06	3.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GATM—coronary artery disease	2.91e-06	3.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.88e-06	3.18e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—NOS3—coronary artery disease	2.88e-06	3.18e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	2.81e-06	3.1e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLA2G2A—coronary artery disease	2.78e-06	3.06e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX2—coronary artery disease	2.78e-06	3.06e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA2—coronary artery disease	2.78e-06	3.06e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCH1—coronary artery disease	2.77e-06	3.06e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AK1—coronary artery disease	2.77e-06	3.06e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—coronary artery disease	2.75e-06	3.04e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCG5—coronary artery disease	2.74e-06	3.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX4—coronary artery disease	2.74e-06	3.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HK1—coronary artery disease	2.74e-06	3.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SULT1A1—coronary artery disease	2.74e-06	3.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	2.74e-06	3.02e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—coronary artery disease	2.72e-06	3e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—coronary artery disease	2.72e-06	3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HADHA—coronary artery disease	2.71e-06	2.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA1—coronary artery disease	2.68e-06	2.96e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MDH2—coronary artery disease	2.66e-06	2.93e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPAT—coronary artery disease	2.66e-06	2.93e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UGCG—coronary artery disease	2.66e-06	2.93e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLCD1—coronary artery disease	2.66e-06	2.93e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LPA—coronary artery disease	2.65e-06	2.92e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—coronary artery disease	2.64e-06	2.91e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLCB3—coronary artery disease	2.57e-06	2.83e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PGM1—coronary artery disease	2.56e-06	2.82e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA5—coronary artery disease	2.54e-06	2.8e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—coronary artery disease	2.52e-06	2.78e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—P4HB—coronary artery disease	2.49e-06	2.75e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CKB—coronary artery disease	2.47e-06	2.73e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PYGB—coronary artery disease	2.47e-06	2.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	2.47e-06	2.72e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLA2G1B—coronary artery disease	2.45e-06	2.7e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	2.42e-06	2.67e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	2.39e-06	2.64e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—coronary artery disease	2.38e-06	2.62e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—coronary artery disease	2.38e-06	2.62e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PFKFB3—coronary artery disease	2.32e-06	2.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM2—coronary artery disease	2.32e-06	2.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLIN1—coronary artery disease	2.32e-06	2.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COX5B—coronary artery disease	2.32e-06	2.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DLAT—coronary artery disease	2.32e-06	2.56e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—VCAN—coronary artery disease	2.31e-06	2.54e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDOA—coronary artery disease	2.29e-06	2.52e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DCN—coronary artery disease	2.22e-06	2.45e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—coronary artery disease	2.22e-06	2.45e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—coronary artery disease	2.22e-06	2.45e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SULT1E1—coronary artery disease	2.2e-06	2.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDH2—coronary artery disease	2.16e-06	2.38e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.11e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LIPC—coronary artery disease	2.11e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HBA1—coronary artery disease	2.11e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	2.11e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HK2—coronary artery disease	2.1e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKR1B1—coronary artery disease	2.1e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOC3—coronary artery disease	2.09e-06	2.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LDLR—coronary artery disease	2.08e-06	2.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.08e-06	2.29e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—coronary artery disease	2.06e-06	2.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—coronary artery disease	2.05e-06	2.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC9A1—coronary artery disease	2.05e-06	2.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCLC—coronary artery disease	2.03e-06	2.24e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CETP—coronary artery disease	2.03e-06	2.24e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC27A1—coronary artery disease	2.02e-06	2.22e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SDC1—coronary artery disease	2.01e-06	2.22e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—coronary artery disease	2.01e-06	2.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LCAT—coronary artery disease	1.98e-06	2.18e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.98e-06	2.18e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA4—coronary artery disease	1.94e-06	2.14e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—coronary artery disease	1.92e-06	2.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSMA6—coronary artery disease	1.9e-06	2.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSMB5—coronary artery disease	1.9e-06	2.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.89e-06	2.09e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCLM—coronary artery disease	1.87e-06	2.07e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.87e-06	2.07e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CTGF—coronary artery disease	1.85e-06	2.04e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—coronary artery disease	1.84e-06	2.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMGCR—coronary artery disease	1.84e-06	2.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GOT2—coronary artery disease	1.84e-06	2.03e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.81e-06	2e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.81e-06	2e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.79e-06	1.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HADH—coronary artery disease	1.76e-06	1.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.76e-06	1.94e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLCB1—coronary artery disease	1.69e-06	1.86e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX2—coronary artery disease	1.67e-06	1.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA2—coronary artery disease	1.67e-06	1.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.67e-06	1.84e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.66e-06	1.83e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HK1—coronary artery disease	1.65e-06	1.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX4—coronary artery disease	1.65e-06	1.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.65e-06	1.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.65e-06	1.82e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—coronary artery disease	1.64e-06	1.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCA1—coronary artery disease	1.64e-06	1.81e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HADHA—coronary artery disease	1.63e-06	1.8e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—coronary artery disease	1.62e-06	1.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.61e-06	1.78e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LPA—coronary artery disease	1.59e-06	1.76e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GGT1—coronary artery disease	1.59e-06	1.75e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GOT1—coronary artery disease	1.59e-06	1.75e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—coronary artery disease	1.57e-06	1.73e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.54e-06	1.7e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA5—coronary artery disease	1.53e-06	1.69e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—coronary artery disease	1.51e-06	1.66e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—P4HB—coronary artery disease	1.5e-06	1.65e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.47e-06	1.62e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—coronary artery disease	1.42e-06	1.57e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	1.41e-06	1.56e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—coronary artery disease	1.4e-06	1.55e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—VCAN—coronary artery disease	1.39e-06	1.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAT—coronary artery disease	1.39e-06	1.53e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.38e-06	1.52e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOB—coronary artery disease	1.35e-06	1.48e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DCN—coronary artery disease	1.34e-06	1.47e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—coronary artery disease	1.32e-06	1.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.31e-06	1.44e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.3e-06	1.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LPL—coronary artery disease	1.28e-06	1.42e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LIPC—coronary artery disease	1.27e-06	1.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HBA1—coronary artery disease	1.27e-06	1.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.27e-06	1.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.27e-06	1.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOC3—coronary artery disease	1.26e-06	1.39e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX1—coronary artery disease	1.25e-06	1.38e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LDLR—coronary artery disease	1.25e-06	1.38e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.24e-06	1.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.24e-06	1.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CETP—coronary artery disease	1.22e-06	1.35e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCLC—coronary artery disease	1.22e-06	1.35e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CD36—coronary artery disease	1.22e-06	1.35e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SDC1—coronary artery disease	1.21e-06	1.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.21e-06	1.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.16e-06	1.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.14e-06	1.26e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.14e-06	1.26e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CTGF—coronary artery disease	1.11e-06	1.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GOT2—coronary artery disease	1.1e-06	1.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.1e-06	1.22e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AGT—coronary artery disease	1.1e-06	1.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—coronary artery disease	1.08e-06	1.19e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA1—coronary artery disease	1.06e-06	1.17e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.02e-06	1.12e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.02e-06	1.12e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCA1—coronary artery disease	9.84e-07	1.09e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GOT1—coronary artery disease	9.53e-07	1.05e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GGT1—coronary artery disease	9.53e-07	1.05e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—coronary artery disease	9.38e-07	1.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—POMC—coronary artery disease	9.25e-07	1.02e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—coronary artery disease	8.56e-07	9.45e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	8.48e-07	9.36e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—coronary artery disease	8.45e-07	9.32e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—coronary artery disease	8.43e-07	9.3e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAT—coronary artery disease	8.33e-07	9.19e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOB—coronary artery disease	8.09e-07	8.93e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NOS3—coronary artery disease	8.07e-07	8.9e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—coronary artery disease	7.87e-07	8.68e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LPL—coronary artery disease	7.72e-07	8.52e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX1—coronary artery disease	7.54e-07	8.31e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—coronary artery disease	7.38e-07	8.14e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CD36—coronary artery disease	7.34e-07	8.1e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPP2CA—coronary artery disease	7.25e-07	8e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—coronary artery disease	6.96e-07	7.67e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AGT—coronary artery disease	6.61e-07	7.29e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—coronary artery disease	6.47e-07	7.14e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA1—coronary artery disease	6.4e-07	7.06e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—coronary artery disease	5.64e-07	6.22e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—POMC—coronary artery disease	5.56e-07	6.14e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—coronary artery disease	5.07e-07	5.59e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NOS3—coronary artery disease	4.85e-07	5.35e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—coronary artery disease	4.54e-07	5.01e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.44e-07	4.89e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—coronary artery disease	3.71e-07	4.09e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.73e-07	3.01e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—coronary artery disease	2.23e-07	2.46e-06	CbGpPWpGaD
